Reported Clinical Performance Control the spread of VRE, so it doesn't control you. Spectra™ VRE is a selective and differential chromogenic medium recommended for use in the qualitative detection of gastrointestinal colonization of vancomycin-resistant Enterococcus (VRE) to aid in the prevention and control of VRE in healthcare settings. Spectra VRE allows differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis. Reliable Performance • Correctly classifies patients whether positive or negative • Enables you to control the spread of vancomycin resistance and prevent VRE colonized patients from becoming infected Workflow Simplicity • Conclusive results in 24 hours with rectal swabs and stool specimens • No light sensitivity, so no special handling Economical Solution • Correct classification decreases hospital and patient costs due to false positives and unnecessary isolation • Confirmatory testing is NOT required References: 1. Hidron, A.I. et.al. Infection Control and Epidemiology; 2008; 29:996-1 Oil. Part of Thermo Fisher Scientific

Are you ready for VRE? When you need reliable performance In a cost-effective package, Spectra™ VRE is the clear choice for surveillance and screening. Remel products deliver the science, service, and solutions you can count on when it comes to Healthcare-Associated Infections like VRE. Our expertise is backed by stringent quality assurance, reliable service, on-time delivery, and superior customer support. ; a To learn more about Remel Healthcare-Associated Infection solutions, visit www.remel.com/hai or contact your local Technical Sales Representative. ..J remel Part of Thermo Fisher Scientific...